Shelton Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Shelton Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,540	Closed	-$205K	–	873
2019 Q2	$205K	Buy	+2,540	New	+$179K	0.01%	762
2018 Q4	–	Sell	-2,540	Closed	-$234K	–	917
2018 Q3	$234K	Hold	2,540	–	–	0.01%	757
2018 Q2	$250K	Hold	2,540	–	–	0.02%	673
2018 Q1	$283K	Sell	2,540 -728	-22%	-$81.6K	0.02%	582
2017 Q4	$336K	Hold	3,268	–	–	0.02%	526
2017 Q3	$308K	Sell	3,268 -337	-9%	-$26.6K	0.02%	552
2017 Q2	$281K	Buy	3,605 +274	+8%	+$20.6K	0.02%	613
2017 Q1	$267K	Buy	3,331 +330	+11%	+$26.2K	0.02%	640
2016 Q4	$236K	Hold	3,001	–	–	0.02%	748
2016 Q3	$234K	Hold	3,001	–	–	0.02%	678
2016 Q2	$206K	Hold	3,001	–	–	0.02%	710
2016 Q1	$214K	Buy	+3,001	New	+$188K	0.02%	696

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Shelton Capital Management's CMD Position: Q3 2019 in Review

Shelton Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 2,540 shares — an estimated $205K sold.

Shelton Capital Management first reported a position in CMD in Q1 2016 and held it in 12 quarters. The position peaked at $336K in Q4 2017. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

Shelton Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
Shelton Capital Management sold 2,540 Cantel Medical Corporation shares in Q3 2019, an estimated $205K.
Shelton Capital Management first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 12 quarters.
Shelton Capital Management's Cantel Medical Corporation position peaked at $336K in Q4 2017.
244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Shelton Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.